Platform
The two key technology platforms, nu-TECH and nu-GENE, developed with emphasis, utilize optimized TIL rapid manufacturing techniques and precise gene editing methods. These platforms significantly alleviate T-cell exhaustion, enhancing their persistence and cytotoxicity, thereby overcoming the suppressive tumor microenvironment and achieving improved prognosis for patients.
-
nu-TECH
Utilize engineering techniques to mitigate T cell exhaustion, augment stemness, and amplify functional T cells
The utilization of cutting-edge technology and gene editing techniques is employed to enhance the desiccation resistance and memory capacity of T cells, thereby decelerating their depletion rate. This approach aims to achieve rapid expansion of functional T cells and augment their cytotoxicity.
-
nu-GENE
Cutting-edge T-cell target screening and gene editing platform for unique immunotherapy with precise experimental cell manipulation.
Through T-cell engineering and the establishment of unique in vitro and in vivo models, our objective is to achieve precise and functional assessment of T-cell immunotherapy.